Search research articles
Contact Us
Filters
Showing results (341-350 of 449) with videos related to
Page
of 45
Sort By:
Journal of Psychosomatic Research
|
February 25, 2021
Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Stephanie Rodgers, Pasquale Calabrese, Vladeta Ajdacic-Gross, et al.
Communications Biology
|
May 3, 2022
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
Diego Cantoni, Martin Mayora-Neto, Nazia Thakur, et al.
Multiple Sclerosis and Related Disorders
|
August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC score
Gabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 1, 2026
Evaluating Individual Level Performance of Polygenic Risk Scores Using Early Onset High Genetic Risk Coronary Artery Disease as a Benchmark
Shengxin Liang, Min Seo Kim, Yang Sui, et al.
Plos One
|
May 3, 2011
Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders
Aiden Haghikia, Moritz Perrech, Bartosz Pula, et al.
Multiple Sclerosis and Related Disorders
|
August 7, 2022
Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry
Mina Stanikić, Anke Salmen, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders
|
August 4, 2025
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study
Klaus Schmierer, Heinz Wiendl, Frederik Barkhof, et al.
Journal of Medical Virology
|
June 15, 2022
Human seasonal coronavirus neutralization and COVID-19 severity
David A Wells, Diego Cantoni, Martin Mayora-Neto, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 25, 2023
Opto-Lipidomics of Tissues
Magnus Jensen, Shiyue Liu, Elzbieta Stepula, et al.
Neurology and Therapy
|
July 14, 2023
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
Stephen L Hauser, Ludwig Kappos, Amit Bar-Or, et al.
Page
of 45
Search research articles
Search
Showing results (341-350 of 449) with videos related to
Sort By:
Page
of 45
Journal of Psychosomatic Research
|
February 25, 2021
Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Stephanie Rodgers, Pasquale Calabrese, Vladeta Ajdacic-Gross, et al.
Communications Biology
|
May 3, 2022
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
Diego Cantoni, Martin Mayora-Neto, Nazia Thakur, et al.
Multiple Sclerosis and Related Disorders
|
August 22, 2025
Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC score
Gabriel Bsteh, Vincenzo Introcaso, Christiane Gradl, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 1, 2026
Evaluating Individual Level Performance of Polygenic Risk Scores Using Early Onset High Genetic Risk Coronary Artery Disease as a Benchmark
Shengxin Liang, Min Seo Kim, Yang Sui, et al.
Plos One
|
May 3, 2011
Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders
Aiden Haghikia, Moritz Perrech, Bartosz Pula, et al.
Multiple Sclerosis and Related Disorders
|
August 7, 2022
Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry
Mina Stanikić, Anke Salmen, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders
|
August 4, 2025
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study
Klaus Schmierer, Heinz Wiendl, Frederik Barkhof, et al.
Journal of Medical Virology
|
June 15, 2022
Human seasonal coronavirus neutralization and COVID-19 severity
David A Wells, Diego Cantoni, Martin Mayora-Neto, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 25, 2023
Opto-Lipidomics of Tissues
Magnus Jensen, Shiyue Liu, Elzbieta Stepula, et al.
Neurology and Therapy
|
July 14, 2023
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
Stephen L Hauser, Ludwig Kappos, Amit Bar-Or, et al.
Page
of 45